| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
4
5
3
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
A-
(Buy)
|
Fund Holdings
The fund invests in shares of companies that management believes to be undervalued.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 1.98 | 1.98 |
| Stocks | 94.0 | 94.0 |
| Bonds | 0.0 | 0.0 |
| Other | 0.17 | 0.17 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 3.85 | 3.85 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Pfizer Inc | PFE | 12.56 | 4.94 |
| JPMorgan Chase & Co | JPM | 25.29 | 3.96 |
| AT&T Inc | T | 6.7 | 3.21 |
| Merck & Co Inc | MRK | 19.39 | 3.07 |
| Johnson & Johnson | JNJ | 22.65 | 2.64 |
| Procter & Gamble Co | PG | 16.1 | 2.32 |
| Phillips 66 | PSX | 25.62 | 2.09 |
| MetLife Inc | MET | 36.22 | 2.05 |
| Cisco Systems Inc | CSCO | 24.94 | 1.91 |
| International Paper Co. | IP | 16.79 | 1.87 |
